Tissue Engineering Strategies for Retina Regeneration

Autor: Mark S. Humayun, Kahini H. Patel, Magdalene J. Seiler, Deepthi S. Rajendran Nair, Vinoy Thomas, Juan Carlos Martinez Camarillo, Biju B. Thomas
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
retinal pigment epithelium
Regenerative Medicine
Eye
lcsh:Technology
lcsh:Chemistry
0302 clinical medicine
Tissue engineering
Stem Cell Research - Nonembryonic - Human
General Materials Science
Induced pluripotent stem cell
Instrumentation
lcsh:QH301-705.5
Retinal regeneration
Fluid Flow and Transfer Processes
retinal degenerative diseases
General Engineering
lcsh:QC1-999
Computer Science Applications
Cell biology
medicine.anatomical_structure
tissue engineering
Stem cell
Biotechnology
Adult stem cell
biomaterials
Bioengineering
03 medical and health sciences
stem cells
medicine
Eye Disease and Disorders of Vision
age-related macular degeneration
Transplantation
Retina
Retinal pigment epithelium
Stem Cell Research - Induced Pluripotent Stem Cell
5.2 Cellular and gene therapies
business.industry
lcsh:T
Process Chemistry and Technology
Neurosciences
Stem Cell Research
030104 developmental biology
lcsh:Biology (General)
lcsh:QD1-999
lcsh:TA1-2040
030221 ophthalmology & optometry
business
lcsh:Engineering (General). Civil engineering (General)
lcsh:Physics
Zdroj: Applied Sciences, Vol 11, Iss 2154, p 2154 (2021)
Applied Sciences (Switzerland), vol 11, iss 5
Applied sciences (Basel, Switzerland), vol 11, iss 5
ISSN: 2076-3417
Popis: The retina is a complex and fragile photosensitive part of the central nervous system which is prone to degenerative diseases leading to permanent vision loss. No proven treatment strategies exist to treat or reverse the degenerative conditions. Recent investigations demonstrate that cell transplantation therapies to replace the dysfunctional retinal pigment epithelial (RPE) cells and or the degenerating photoreceptors (PRs) are viable options to restore vision. Pluripotent stem cells, retinal progenitor cells, and somatic stem cells are the main cell sources used for cell transplantation therapies. The success of retinal transplantation based on cell suspension injection is hindered by limited cell survival and lack of cellular integration. Recent advances in material science helped to develop strategies to grow cells as intact monolayers or as sheets on biomaterial scaffolds for transplantation into the eyes. Such implants are found to be more promising than the bolus injection approach. Tissue engineering techniques are specifically designed to construct biodegradable or non-degradable polymer scaffolds to grow cells as a monolayer and construct implantable grafts. The engineered cell construct along with the extracellular matrix formed, can hold the cells in place to enable easy survival, better integration, and improved visual function. This article reviews the advances in the use of scaffolds for transplantation studies in animal models and their application in current clinical trials.
Databáze: OpenAIRE